Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
Thrombotic microangiopathy associated with interferon beta.
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling.
Value and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000.
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.
Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy.
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine.
Cyclophosphamide
GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach to Treat Multiple Sclerosis: Patients Receiving First in Class GNbAC1 Mab Are Stable After One Year
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis.
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis.
Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
2-chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.
Treatment satisfaction, adherence and behavioral assessment in patients de - escalating from natalizumab to interferon beta.
Decreased microglial activation in MS patients treated with glatiramer acetate.

Pages